CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 56 enrolled
Drug / intervention
Placebo +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03934710
NCT03934710Phase 1Completed
CompareCT.gov

Mood Effects of Serotonin Agonists Extended

University of Chicago·interventional·Posted May 2, 2019·Updated Nov 29, 2023

In Brief

A Phase 1 clinical trial evaluating Placebo, Serotonin agonist - 13ug, and 1 other intervention for Healthy. Completed, enrolled 56 participants across 1 site.

Detailed Summary

In this study we are examining the effects of repeated very low doses of serotonin agonists on mood individuals with negative mood.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 1CompletedFinished
2020202120222023202420252026
First PostedMay 2, 2019
Enrollment StartApr 20, 2019
Primary CompletionJun 7, 2021
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 7.2 years ago

Interventions

Placebodrug

Drug will be administered in solution form

Serotonin agonist - 13ugdrug

13ug lysergic acid diethylamide

Serotonin agonist - 26ugdrug

26ug lysergic acid diethylamide